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Abstract: Helicobacter pylori (H.pylori) colonize the gastric mucosa of approximately 50 % of the world's 
population that involved in chronic gastritis. The relationship between Hp colonization and gastric inflammation is 
widely accepted. Polymorphisms in inflammation related genes such as cytokines were thought to partly determine 
the outcome of Hp infection and progression of gastritis. Interleukin IL -17A and IL-17F are inflammatory cytokines 
expressed by a novel subset of CD4+ Th cells, play important function in inflammation. Aimed: we evaluate 
association of IL-17A G197A and IL-17F A7488G polymorphisms with gastritis, Polymorphonuclear (PMN) and 
Monoculear (MN) infiltration in related to Hp. Methods: According to rapid urease test, PCR 16srRNA, urea and 
histological examination of biopsies, patients were classified Hp-infected and Hp-uninfected. The histological 
severity of gastritis was graded from normal to severe based on the degree of MN cell and PMN leukocyte 
infiltration, chronic gastritis and chronic active gastritis. Polymorphism in IL-17A G197A and IL-17F A7488G were 
evaluated by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Results: AG, GG, 
AG/AA carriers of IL-17A G197A and AA, GA, GG, GA/GG carriers of IL-17F A7488G polymorphisms were not 
associated with MN infiltration, PMN infiltration, chronic gastritis and Chronic active gastritis in Hp-infected and 
Hp-uninfected groups (p > 0.05). AA genotype of IL-17A G197A was related to chronic gastritis and PMN 
infiltration in Hp-uninfected group. Conclusion: IL-17A G197A substitution may be a risk factor for development 
gastritis in Hp-uninfected patients, also affect the pathway MN cell production pathways. 
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Introduction 
Hp is a spiral-shaped gram negative flagellate 
bacterium that colonizes the gastric mucosa of 
approximately 50 % of the world's population (1). Hp 
infection induces inflammation in gastric mucosa that 
involved in chronic gastritis (2-4). Hp-associated 
inflammatory reaction is defined by an immense 
mucosal infiltration of macrophages, PMN 
leukocytes, T cells, and plasma (5-7). Gastritis may 
progress to other steps such as gastric atrophy, 
intestinal metaplasia, and finally gastric cancer. It may 
also lead to precancerous lesions looking like 
monoclonal lymphocytic proliferation, lymphoid 
follicle (LF) development and later primary gastric 
lymphoma (PGL) which develop only in a portion of 
individual with gastritis because of multifactorial 
effects of host virulence and bacterial factors that 
vary among different racial and social groups (8, 
9). Studies on the evolution of gastric cancer report 
that genetic susceptibility and chronic Hp infection 
are important parts of a complex interaction to launch 
gastric carcinogenesis. Genetic variations in 
inflammation-associated genes, especially cytokines, 
are seems to play a role in the outcome of Hp 
infection and development of gastric lesions (10-13). 
Among host factors several inflammatory proteins 
including chemokines, cytokines and growth factors 
have been known to control adaptive immune 
response in contrast to Hp infection (14, 15). Firstly, 
El-Omar was reported an association between gastric 
cancer risk and interleukin 1 gene cluster 
polymorphisms (16). Studies from the western world 
show roles of anti - and pro -inflammatory cytokine 
genes such as interleukin (IL)-1β, its receptor 
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antagonist (IL-1RN), IL-10, and tumor necrosis factor 
(TNF-α) gene polymorphisms affect risk for gastritis 
(17) and GC (18), including its precursors (16, 19, 
20). However Asian studies did not find any such 
association (21-23). Recently, an inflammation 
pathway of IL-23/IL-17 axis reported to play 
fundamental role in inflammatory and autoimmune 
diseases (24), such as psoriasis (25), lupus nephritis 
(26), and intestinal inflammation (27). lately, a lineage 
of CD4+ T helper cells that named Th17 cells has 
been specified as a unique subset of effector T helper 
cells, which undermine the Th1 and Th2 lineages (28, 
29). Th17 cells, in particular according to the 
production of IL-17A and IL-17F, are generally 
accepted as a proinflammatory now. These cells have 
been related with pathogenesis of a raising list of 
inflammatory and autoimmune diseases, such as 
inflammatory bowel diseases, psoriasis and 
rheumatoid arthritis (30, 31). The six members IL-17 
family of cytokines contains, IL-17A (also called IL-
17), IL-17B, IL-17C, IL-17D, IL-17E and IL- 17F as 
IL-17A is the founding member. Despite the fact that 
little is known about the others but IL-17F was 
indicated is involved intense homology to IL-17A. IL-
17F was reported to induce the expression of various 
cytokines, chemokines and adhesion molecules also 
these features shown to IL-17A, but reported IL-17F 
had significantly weaker activity than IL-17A (32). 
Furthermore, growing evidences suggested the role of 
IL-17A in Hp-related gastric diseases (32). Recently, 
Polymorphisms of IL-17A G197A (rs2275913) and 
IL-17F A7488G (p.His161Arg rs763780) have been 
recognized to be related with the susceptibility to 
rheumatoid arthritis and ulcerative colitis, respectively 
(33, 34). Anyway, they have not been evaluated with 
respect to precancerous risk. In the present study, we 
evaluated the IL-17A G197A and IL-17F A7488G 
polymorphisms of each single nucleotide 
polymorphism (SNP) with types of gastritis, chronic 
active gastritis and chronic gastritis, according to its 
clinicopathological features, interactions with cellular 
infiltration and role of Hp in a population from central 
Iran. 
 
Subjects and Methods 
A total of 435 patients with nonulcer dyspepsia 
(NUD) who were undergoing upper gastrointestinal 
endoscopy were tested for Hp infection using in-house 
RUT. Hp-infected and uninfected patients were 
determined by the rapid urease test, PCR 16srRNA, 
urea and histological examination of biopsies taken 
from the corpus. Patients were classified as Hp-
infected only if the three tests were positive and Hp-
uninfected if the three tests were negative, 
respectively. Demographic and clinical data were 
obtained through interview using a standard clinical 
pro forma. Exclusion criteria included history of 
gastric neoplasm or surgery, liver disease, and 
previous treatment with nonsteroidal anti-
inflammatory drugs, proton pump inhibitors, 
antibiotics, or bismuth salts. Informed consents for 
participation were signed by all the study subjects. 
The study protocol was approved by the Clinical 
Research Ethics Committee of the Shahrekord 
University of Medical Sciences. 
Histological examination 
Sections of biopsy specimens were embedded 10 
% buffered formalin and stained with hematoxylin 
and eosin to examine gastritis and with giemsa to 
detect Hp. The histological severity of gastritis was 
blindly graded from normal to severe based on the 
grade of PMN leukocyte and MN cell infiltration, 
chronic gastritis and chronic active gastritis according 
to the updated sydney system (Manxhuka-Kerliu et 
al., 2009) on a four-point scale: 0, no; 1, mild; 2, 
moderate; and 3, severe changes. 
DNA isolation 
Genomic DNA was extracted from biopsies 
taken from the corpus using Biospin Tissue Genomic 
DNA Extraction Kit (Bio Flux, Japan). All extracted 
DNA was resuspended in UltraPure RNAse/DNAse-
Free Distilled water. 
Genotyping for IL-17A G197A and IL-17F A7488G 
polymorphisms 
Genotyping analysis IL-17A and IL-17F 
genotyping were performed by polymerase chain 
reaction restriction fragment length polymorphism 
(PCR-RFLP) as reported by Wu et al (32). Primer 
sequences for IL-17A G197A and IL-17F A7488G 
variations are shown in Table I. The PCR 
amplification was performed in a total volume of 25 
µL mixture containing: 100-ng genomic DNA, 1.0 
µM of each primer, 200 µM of each dNTP, 2.0 mM of 
MgCl2 and 1.0 U Taq DNA polymerase and 10X Taq 
buffer (Fermentas) using the Biometra Tgradient 96 
(Biometra, Germany). PCR conditions were as 
follows: denaturation at 96 °C for 5 min, followed by 
33 cycles of 95 °C for 60 s, 65 °C for 60 s, and 72 °C 
for 50 s. A final extension was carried out at 72 °C for 
7 min for IL-17A; denaturation at 95 °C for 6 min, 
followed by 33 cycles of 95 °C for 60 s, 65 °C for 55 
s, and 72 °C for 60 s. A final extension was carried 
out at 72 °C for 6 min for IL-17F and products 
cooling down to 4 °C. The PCR products were 
digested by restriction endonuclease XagI (Fermentas) 
for IL-17A G197A and NlaIII (Fermentas) for IL-17F 
A7488G, according to the manufacturer’s instructions, 
at 37°C overnight and then separated by 10% 
polyacrylamide gel electrophoresis. Gel analysis was 
performed after staining with ethidium bromide. PCR 
products were shown to be digested into three types of 
fragments (Fig. 1). To confirm the genotyping results, 
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selected PCR samples in both groups including 
samples of each genotype were re-genotyped by other 
laboratory personnel. There was no difference after 
genotyping the randomly selected samples.  
 
Table I .PCR primers for amplification of IL-17A G197A and IL-17F A7488G genes 
Primer Primer sequence Size of PCR 
product (bp) 
References 
IL-17A Sense 5´-AACAAGTAAGAATGAAAAGAGGACATGGT-3´  
anti-sense 5´-CCCCCAATGAGGTCATAGAAGAATC-3´ 
102 bp  (32) 
IL-17F   sense 5´-ACCAAGGCTGCTCTGTTTCT-3´ 
anti-sense 5´-GGTAAGGAGTGGCATTTCTA-3  ´
143 bp (32) 
 
 
Fig 1: PCR-RFLP polyacrylamide gel electrophoresis 
of the IL-17A G197A and IL-17F A7488G 
polymorphisms indicating (a) IL-17A G197A, No.1, 2, 
5, 9 (AA = 102 bp) 4,7,8 (AG = 102, 68, 34 bp*) 3,6 
(GG= 68, 34 bp) genotypes and (b) IL-17F A7488G, 
No. 2, 4, 6 (AA = 80, 63 bp) 3,7 (GA = 143, 80, 63 bp) 
1,5( GG= 143 bp) genotypes; * 34 bp is too short to 
detect and is not present in the gel. 
 
Statistical analysis 
Data were analyzed using SPSS 16.0(SPSS Inc., 
Chicago, IL). Hardy–Weinberg equilibrium in all 
subjects was analyzed with the x2 goodness-of-fit test 
before the ensuing analyses. The confounding effects 
of age and gender were adjusted using conditional 
logistic regression. Logistic regression analyses were 
used to calculate odds ratios (ORs) and 95% 
confidence intervals (CIs) for gastritis in association 
with genotypes. Also statistical analysis was performed 
by non paired t test depending on the data set. Values 
of p <0.05 were considered as significant. 
 
Results  
Demographic and clinical characteristics 
Genomic DNA was obtained among the 193 
(44.4%) Hp-infected and 242(55.6%) Hp-uninfected 
gastritis then the DNA all subjects were genotyped. 
The demographic data of all subjects were 
demonstrated in Table II. There was no significant 
difference between the two groups with respect to the 
age and gender distribution (p > 0.05).  
 
 
 
Table II. Demographic data of study subjects 
Variable Hp-infected (%) Hp-Uninfected (%) P value  
Overall  193(44.4%) 242(55.6%)  
Gender 
Male 
Female 
 
78(41.9%) 
115(46.2%) 
 
108(58.1%)   
134(53.8%) 
 
0.377 
Age  Mean±SD (year) 47.24 ±17.28 48.29 ±19.49 0.556 
 
IL-17F 7488 and IL-17A 197 genotypes and Hp infection susceptibility  
The frequencies of the polymorphism in cases and controls are shown in Table III. Frequencies of IL-17A 197 
(AA, 7.9%; AG, 44.7% and GG, 47.4%; AG/AA, 51.9%) and IL-17F 7488 (AA, 81.2%; GA, 17.0% and GG, 1.7%; 
GA/GG, 18.8%) genotypes in Hp-infected were compared those (AA, 7.3%; AG, 46.3% and GG, 46.1%; AG/AA, 
53.5%) and (AA, 81.2%; AG, 16.9% and GG, 1.9%; GA/GG, 18.8%) in Hp-uninfected respectively. 
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Table III. Adjusted Odds Ratios (ORs) and 95% confidence intervals (CIs) for Hp-infected in relation to IL-17F 
7488 and IL-17A 197 genotypes 
Genotype Hp-infected (%) Hp-Uninfected (%) P value OR# (95% CI) 
IL-17A G197A 
AA 15(7.9%) 16(7.3%) 0.489 0.924(0.444-1.923) 
AG 85(44.7%) 101(46.3%) 0.412 1.066(0.721-1.576) 
GG 90(47.4%) 101(46.1%) 0.439 0.951(0.644-1.404) 
AG/AA* 98(51.9%) 116(53.5%) 0.412 1.066(0.722-1.576) 
IL-17F A7488G 
AA 143(81.2%) 173(81.2%) 0.550 0.998(0.599-1.664) 
GA 30(17.0%) 36(16.9%) 0.538 0.990(0.582-1.685) 
GG 3(1.7%) 4(1.9%) 1.000 1.105(0.244-5.003) 
GA/GG** 33(18.8%) 40(18.8%) 0.550 1.002(0.601-1.671) 
# Adjusted for age and gender. 
*A allele, common between homozygote (AA) and heterozygote (AG) situation of IL-17A G197A genotype. 
**G allele, common between homozygote (GG) and heterozygote (GA) situation of IL-17F A7488G genotype. 
 
 
Table IV. Odds Ratios (ORs) and 95% Confidence Intervals (CIs) for gastritis in relation to IL-17A G197A and IL-
17F A7488G genotypes in Hp-infected subjects 
Genotype 
 
Hp-infected (%) Chronic active 
Gastritis(%)  
Chronic 
Gastritis(%) 
P value  OR# (95% CI) 
IL-17A G197A 
AA 11(8.3%) 5(7.0%) 6(9.7%) 0.406 0.707(0.205-2.441) 
AG 61(45.9%) 33(46.5%) 28(45.2%) 0.509 1.055(0.532-2.090) 
GG 61(45.9%) 33(46.5%) 28(45.2%) 0.509 1.055(0.532-2.090) 
AG/AA* 72(54.5%) 38(53.5%) 34(55.7%) 0.468 0.914(0.460-1.819) 
IL-17F A7488G 
AA 99(81.8%) 55(85.9%) 44(77.2%) 0.157 1.806(0.707-4.612) 
GA 19(15.7%) 7(10.9%) 12(21.1%) 0.101 0.461(0.168-1.265) 
GG 3(2.5%) 2(3.1%) 1(1.7%) 1.000 1.839(0.162-20.828) 
GA/GG** 22(18.2%) 9(14.1%) 13(22.8%) 0.157 0.554(0.217-1.415) 
# Adjusted for age and gender. 
*A allele, common between homozygote (AA) and heterozygote (AG) situation of IL-17A G197A genotype. 
**G allele, common between homozygote (GG) and heterozygote (GA) situation of IL-17F A7488G genotype. 
 
 
IL-17A G197A and IL-17F A7488G polymorphisms 
and gastritis 
In our study population, IL-17A G197A (AA, 
AG, GG, AG/AA) and IL-17F A7488G (AA, GA, GG, 
GA/GG) variants and alleles evaluated in Hp-infected 
and Hp-uninfected population. All genotypes and G 
(GA/GG) allele of IL-17F A7488G also some 
genotypes (GA, GG) and A (AG/AA) allele of IL-17A 
G197A were not associated with chronic active 
gastritis and chronic gastritis in both groups (p > 0.05). 
AA genotype of IL-17A G197A was associated with 
decreased risk for chronic gastritis (p = 0.017) in Hp-
uninfected subjects (Table IV and V). 
IL-17A G197A and IL-17F A7488G polymorphisms 
and cellular infiltration 
IL-17A G197A and IL-17F A7488G genotypes 
evaluated with grade of MN and PMN infiltration on 
Hp-infected and Hp-uninfected groups. The results are 
compared in Table VI and Table VII. All genotypes of 
IL-17F A7488G also some genotypes of IL-17A 
G197A (GA, GG) were not associated with MN and 
PMN infiltration in both groups (p > 0.05). AA 
genotype of IL-17A G197A was related with increased 
PMN infiltration (p = 0.007) in Hp-uninfected subjects.  
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Table V Odds Ratios (ORs) and 95% Confidence Intervals (CIs) for gastritis in relation to IL-17A G197A and 
IL-17F A7488G genotypes in Hp-Uninfected subjects 
Genotype 
 
Hp-
uninfected 
(%) 
Chronic active 
Gastritis(%) 
Chronic 
Gastritis(%) 
P value OR# (95% CI) 
IL-17A G197A 
AA 9(12.2%) 6(27.3%) 3(5.8%) 0.017 6.125(1.372-27.352) 
AG 33(44.6%) 8(36.4%) 25(48.1%) 0.252 0.617(0.221-1.720) 
GG 32(43.2%) 8(36.4%) 24(46.2%) 0.303 0.667(0.239-1.859) 
AG/AA** 42(56.8%) 14(63.6%) 28(53.8%) 0.303 1.500(0.538-4.183) 
IL-17F A7488G 
AA 61(82.4%) 20(90.9%) 41(78.8%) 0.321 1.500(0.538-4.183) 
GA 12(16.2%) 2(9.1%) 10(19.2%) 0.491 0.420(0.084-2.099) 
GG 1(1.3%) 0(0.0%) 1(1.9%) 1.000 0.689(0.591-0.803) 
GA/GG** 13(17.6%) 2(9.1%) 11(21.2%) 0.321 0.373(0.075-1.844) 
# Adjusted for age and gender. 
*A allele, common between homozygote (AA) and heterozygote (AG) situation of IL-17A G197A genotype. 
**G allele, common between homozygote (GG) and heterozygote (GA) situation of IL-17F A7488G genotype. 
 
Table VI Association of IL-17A G197A and IL-17F A7488G genotypes with cellular infiltration in Hp-
infected subjects 
Genotype No. Monoculear 
infiltration* 
Polymorphonuclear infiltration* 
IL-17A 
AA 
AG 
GG 
 
11 
60 
72 
 
1.09 ±0.701 (0-3) 
1.42 ±0.641 (0-3) 
1.32 ±0.728 (0-3) 
 
0.45 ±0.522 (0-3) 
0.57 ±0.563 (0-3) 
0.49 ±0.531 (0-3) 
P value  0.434 0.691 
IL-17F 
AA 
GA 
GG 
 
108 
22 
3 
 
1.36 ±0.703 (0-3) 
1.23 ±0.757 (0-3) 
1.33 ±0.577 (0-3) 
 
0.52 ±0.520 (0-3) 
0.38 ±0.590 (0-3) 
0.67 ±0.577 (0-3) 
P value  0.652 0.367 
*The histopathological parameters were scored as: 0, none; 1, mild; 2, moderate; 3, severe  
 
Table VII Association of IL-17A G197A and IL-17F A7488G genotypes with cellular infiltration in 
Hp- Uninfected subjects 
Genotype No. Monoculear inflitration* Polymorphonuclear infiltration* 
IL-17A 
AA 
AG 
GG 
 
9 
44 
42 
 
1.67 ±0.707 (0-3) 
1.11 ±0.784 (0-3) 
1.02 ±0.780 (0-3) 
 
0.67 ±0.500 (0-3) 
0.18 ±0.390 (0-3) 
0.24 ±0.532 (0-3) 
P value  0.081 0.007 
IL-17F 
AA 
GA 
GG 
 
76 
17 
2 
 
1.21 ±0.805 (0-3) 
0.76 ±0.562 (0-3) 
0.50 ±0.707 (0-3) 
 
0.29 ±0.512 (0-3) 
0.12 ±0.332 (0-3) 
0.00 ±0.00 (0-3) 
P value  0.053 0.317 
 *The histopathological parameters were scored as: 0, none; 1, mild; 2, moderate; 3, severe  
 
Discussion 
In this study, we evaluated relationships between 
polymorphisms of IL-17A and IL-17F genes and 
gastritis in Iranian population. In the present study we 
found that frequencies of IL-17A and IL-17F 
genotypes and alleles were not comparable in 
infected-Hp patients and uninfected Hp subjects. In 
other hand we found that genotype of IL-17F 7488AA 
was related to gastritis in non-infected HP subjects but 
not in Hp-infected patients that suggest this genotype 
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of IL-17F may be independent on Hp intraction is 
associated with gastritis. Though, we found that 
variants of IL-17A gene, GG, AG, AA, and IL-17F, 
GA, GG, were not associated with gastritis in non-
infected patients and patients infected with Hp. These 
findings suggest that IL-17A and IL-17F 
polymorphisms may independent of the presence or 
absence of Hp has no effect on gastritis (chronic 
active gastritis and chronic gastritis). Previously 
Arisawa et al showed that IL-17F 7488 polymorphism 
and Hp infection increase the activity and 
inflammation scores significantly in Japanese 
populations (35). The disparity between the results of 
this study and studies reporting significant risks 
associated with some of these alleles may be due to 
different patient groups, different populations, sample 
size power, differing clinical characteristics, controls 
drawn from high risk areas for chronic gastritis, 
multiple comparisons involving several genotypes and 
several histological endpoints, or confounding factors 
from other environmental co-factors. Whereas, one 
study suggest that the IL-17F 7488GA and GG 
genotype significantly increased gastric cancer risk 
tended to vary with tumor sites and histological types 
(32). We suggest this incoherence may indicate that 
the effect of some IL-17F genotypes on inflammatory 
processes varied with both inflammatory response 
steps and site of gastritis. This is consistent with the 
different mechanisms of inflammation so that in 
precancerous and gastritis stages some of cytokines 
are dominant and have specific role in start of 
inflammation process but as stage progress, another 
cytokines participate therefore we observe many 
cytokines affection in the latter stages. Also IL-17F 
polymorphism may influence the some steps of gastric 
carcinogenesis bot not all of them. As there is no 
enough biological report that revealed the function of 
IL-17F polymorphism, especially in precancerous, it 
is difficult to fully elucidate this phenomenon about 
our study. A study don’t found association between 
the IL 17A 197 polymorphism and gastric cancer 
susceptibility (32) that has more accordance with our 
study. Also another study reported no significant 
difference in mucosal IL-17A(IL-17) mRNA 
expression between Hp-infected and non-infected 
patients (36) that may accordance with our study too. 
In other hand several studies shown that Hp-infection 
is also associated with a marked production of Th17 
cytokines (37-39). Also demonstrated that IL-17 as a 
proinflammatory cytokine is upregulated in Hp-
infected stomach biopsy in comparison to Hp-
uninfected specimens (38). Another study report that 
Hp-motivated DCs subsequently activate autologous 
CD4+ T cells and induce IL-17 production (40). 
Regarding Hp, Mizuno et al. showed that infection 
with Hp is related with IL-17 production at the site of 
infection (39). According to disease outcome, IL-17 
production seems to be related with ulcerogenesis 
(39). It has been reported that IL-1 and IL-23 seem to 
have major role in the induction of the observed IL-17 
production. Also recent report indicating that IL-23 
contributes to maintaining IL-17 production in Hp-
infected gastric mucosa (41). According our data we 
suggest that IL 17A 197 polymorphism may not affect 
the IL-17A increasing. However, as other reports 
shown, further study such as evaluation of IL-1 
polymorphism, IL-23, IL-17 and IL-1 cytokines will 
be necessary to clarify the function and interaction of 
these polymorphism regarding the histologic response 
and role of Hp infection. 
IL-17F genotypes was not found to be associated 
with neutrophil and lymphocyte infiltration in HP-
infected and HP-uninfected which suggest IL-17F 
genotypes don't affect the production of neutrophil 
and lymphocyte pathway. Also we don’t observed 
relationship between IL-17A genotypes and MN 
inflitration that indicate these genotypes may not 
affect production of lymphocyte pathway. But we 
found significant association between IL-17A 
polymorphism (AA) and PMN infiltration that suggest 
AA genotype may affect production of neutrophil 
pathway. Since this relationship observed in HP-
uninfected but not in HP-infected subjects, we suggest 
that presence or absence HP may affect production of 
neutrophils. About IL-17F, our results may contradict 
to those study that suggest IL-17F 7488 
polymorphism interact with Hp-infection to increase 
the activity and inflammation scores. Albeit, These 
study related to cancer and not pre-cancerous stage 
(32). Also another in vitro and no in vivo study report 
a new role for DCs in the recognition of Hp by 
indicating their capability to conduct a Th17 response 
against Hp and show the presence of IL-17-secreting 
lymphocytes in the gastric mucosa during Hp 
infection (40). In this study in particular, we have 
demonstrated that all genotypes of IL-17F and 
genotypes of GG and AG from IL-17A doesn’t play a 
role in control of Hp-induced gastritis but AA 
genotype of IL-17A may, depend on presence or 
absence of HP, have a role in gastritis. As a report 
shown immune response during Hp infection, 
especially during the chronic stage of infection, may 
induced both Th1 and Th17 (42). We suggest that may 
be an induced inflammatory response by Hp that more 
caused by Th1 cells. Whether these cytokines are 
independent mediator in the pathogenesis of gastritis 
or not cannot be excluded with safety from the 
presented findings. Further investigation is necessary 
to elucidate fully the exact role of IL-17A and IL-17F 
in the pathogenesis of gastritis. 
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